In conclusion, this work defines a novel tumor‐suppressive E3 ubiquitin ligase RNF182 which induces ubiquitination and degradation of p65 and consequently suppresses the transcription of PDL1, therefore, alleviating immunosuppression and cancer development. This evidence concerns the gene RNF182 and cancer.